The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA Peptide Update: Category 2 Removals Explained BPC 157 Capsules Vios Compounding